Loading
NASDAQHealthcareMedical - Instruments & Supplies
Latest quote
$33.21
+$0.18 · +0.54%
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
Latest quote
$33.21
+$0.18 · +0.54%
After-hours
$33.21
$0.00 · 0.00%
Sep 16, 7:30 PM ET
Regular session · ET · Market data may be delayed.
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
Day range
Current $33.21
52-week range
Current $33.21
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
47
Fair Value
Sentiment
54
Mixed
Risk
55
Elevated Risk
Momentum
39
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
Day range
Current $33.21
52-week range
Current $33.21
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 593.82M USD | 573.45M USD | 665.07M USD | 555.5M USD | 513.7M USD |
| Cost of goods sold | 323.54M USD | 318.83M USD | 431.82M USD | 324.88M USD | 299.19M USD |
| Gross profit | 270.28M USD | 254.62M USD | 233.26M USD | 230.62M USD | 214.51M USD |
| Research and development | 30.39M USD | 31.52M USD | 33.96M USD | 27.54M USD | 22.41M USD |
| Selling, general, and administrative | 251.16M USD | 253.08M USD | 281.5M USD | 227.1M USD | 188.5M USD |
| Operating expenses | 281.55M USD | 284.6M USD | 315.45M USD | 254.64M USD | 210.91M USD |
| Interest income | 18.78M USD | 33.18M USD | 43.74M USD | 20.29M USD | 632K USD |
| Interest expense | — | — | — | 4.59M USD | 2.04M USD |
| Depreciation and amortization | 61.21M USD | 90.74M USD | 85.58M USD | 53.7M USD | 56.87M USD |
| Operating income | −11.27M USD | −29.98M USD | −82.2M USD | −24.02M USD | 3.6M USD |
| Net income | −55.76M USD | −164.9M USD | −14.26M USD | −428.96M USD | 110.75M USD |
Company facts updated Sep 17, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$43.00
29.48% upsideCash distributions grouped by calendar year; partial years are marked.
$0.40
2021 complete year0.0% since 2017
$0.40
2,017
$0.40
2,018
$0.40
2,019
$0.40
2,020
$0.40
2,021
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Dec 2, 2021 | $0.10Quarterly | Dec 3, 2021 | Dec 23, 2021 |
Dividend | Sep 2, 2021 | $0.10Quarterly | Sep 3, 2021 | Sep 24, 2021 |
Dividend | Jun 3, 2021 | $0.10Quarterly | Jun 4, 2021 | Jun 25, 2021 |
Dividend | Mar 4, 2021 | $0.10Quarterly | Mar 5, 2021 | Mar 26, 2021 |
Dividend | Dec 3, 2020 | $0.10Quarterly | Dec 4, 2020 | Dec 17, 2020 |
Dividend | Sep 3, 2020 | $0.10Quarterly | Sep 4, 2020 | Sep 25, 2020 |
Ex-dividend Dec 2, 2021
$0.10
Quarterly
Record Dec 3, 2021 · Payment Dec 23, 2021
Ex-dividend Sep 2, 2021
$0.10
Quarterly
Record Sep 3, 2021 · Payment Sep 24, 2021
Ex-dividend Jun 3, 2021
$0.10
Quarterly
Record Jun 4, 2021 · Payment Jun 25, 2021
Ex-dividend Mar 4, 2021
$0.10
Quarterly
Record Mar 5, 2021 · Payment Mar 26, 2021
Ex-dividend Dec 3, 2020
$0.10
Quarterly
Record Dec 4, 2020 · Payment Dec 17, 2020
Ex-dividend Sep 3, 2020
$0.10
Quarterly
Record Sep 4, 2020 · Payment Sep 25, 2020
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI43.15M0.00%2.3T USD0.03%$371.26-0.42%
Vanguard Morningstar Small-Cap ETFVB31.15M0.02%185.3B USD0.03%$288.98-0.66%
Vanguard Morningstar Small-Cap Value ETFVBR19.79M0.03%68.2B USD0.05%$238.83-0.84%
Vanguard Extended Market ETFVXF15.54M0.02%95.4B USD0.05%$234.39-0.32%
State Street SPDR Portfolio S&P 600 Small Cap ETFSPSM12.54M0.08%16.14B USD0.03%$54.43-0.42%
Vanguard Russell 2000 ETFVTWO7.89M0.04%18B USD0.06%$115.07-0.43%
Schwab U.S. Small-Cap ETFSCHA6.53M0.03%22.03B USD0.03%$33.06-0.29%
Dimensional - US Small Cap Value ETFDFSV5.97M0.07%8.37B USD0.30%$39.17-1.06%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRVanguard Extended Market ETFVXFState Street SPDR Portfolio S&P 600 Small Cap ETFSPSMVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHADimensional - US Small Cap Value ETFDFSVAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
